INTRODUCTION
After a new diagnosis of localized PCa, treatment options may range from AS to radical surgery in most cases.1 Patients are often encouraged to take a second opinion before they decide for the final treatment but this decision-making process could prolong the duration between the diagnosis and potential treatment. The current evidence on the impact of this waiting gap on the surgical and oncological outcomes of the localized PCa is conflicting.2, 3
The Covid-19 pandemic clearly delayed the surgical procedures due to overwhelming case load of infected patients in healthcare systems. Due to rapidly changing healthcare circumstances European Urological Association (EAU) and some national associations including Turkish Urooncology Association published recommendations during the pandemic and suggested a delay for definitive surgical treatment of PCa, between 3 to 6 months with respect to the risk groups of patients.4 Based on these recommendations, we aimed to assess the possible impact of the time duration between diagnosis and radical prostatectomy (RP) on the surgical and oncological outcomes of the disease.